These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2211189)
1. Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease. Keever CA; Flomenberg N; Gazzola MV; Pekle K; Yang SY; Small TN; Collins NH; O'Reilly RJ Hum Immunol; 1990 Sep; 29(1):42-55. PubMed ID: 2211189 [TBL] [Abstract][Full Text] [Related]
2. Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease. Keever CA; Flomenberg N; Small T; Brochstein J; Collins N; Young-Yang S; Insel R; Dupont B; O'Reilly RJ Hum Immunol; 1989 Sep; 26(1):27-38. PubMed ID: 2528525 [TBL] [Abstract][Full Text] [Related]
3. Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Keever CA; Flomenberg N; Brochstein J; Sullivan M; Collins NH; Burns J; Dupont B; O'Reilly RJ Clin Immunol Immunopathol; 1988 Sep; 48(3):261-76. PubMed ID: 3042210 [TBL] [Abstract][Full Text] [Related]
4. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells. Roberts JL; Volkman DJ; Buckley RH J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604 [TBL] [Abstract][Full Text] [Related]
5. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras. Schiff SE; Buckley RH J Immunol; 1987 Apr; 138(7):2088-94. PubMed ID: 2881966 [TBL] [Abstract][Full Text] [Related]
6. Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Donohue J; Homge M; Kernan NA Blood; 1993 Aug; 82(3):1023-9. PubMed ID: 8338933 [TBL] [Abstract][Full Text] [Related]
7. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation. De Villartay JP; Griscelli C; Fischer A Eur J Immunol; 1986 Feb; 16(2):117-22. PubMed ID: 3514234 [TBL] [Abstract][Full Text] [Related]
8. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation. Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111 [TBL] [Abstract][Full Text] [Related]
9. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow. Bacchetta R; Parkman R; McMahon M; Weinberg K; Bigler M; de Vries JE; Roncarolo MG Blood; 1995 Apr; 85(7):1944-53. PubMed ID: 7703497 [TBL] [Abstract][Full Text] [Related]
10. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. Vandekerckhove BA; Krowka JF; McCune JM; de Vries JE; Spits H; Roncarolo MG J Immunol; 1991 Jun; 146(12):4173-9. PubMed ID: 1674954 [TBL] [Abstract][Full Text] [Related]
11. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. Le Deist F; Raffoux C; Griscelli C; Fischer A J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121 [TBL] [Abstract][Full Text] [Related]
12. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules. Chen BP; DeMars R; Hank JA; Sondel PM Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity. Hansen PW; Petersen CM; Povlsen JV; Kristensen T Scand J Immunol; 1987 Mar; 25(3):295-303. PubMed ID: 3494302 [TBL] [Abstract][Full Text] [Related]
14. Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera. Roncarolo MG; Yssel H; Touraine JL; Betuel H; De Vries JE; Spits H J Exp Med; 1988 May; 167(5):1523-34. PubMed ID: 3284961 [TBL] [Abstract][Full Text] [Related]
15. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. Koide J; Engleman EG J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266 [TBL] [Abstract][Full Text] [Related]
16. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
17. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells. Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037 [TBL] [Abstract][Full Text] [Related]
18. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. Kurane I; Meager A; Ennis FA J Exp Med; 1989 Sep; 170(3):763-75. PubMed ID: 2475573 [TBL] [Abstract][Full Text] [Related]
19. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions. Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714 [TBL] [Abstract][Full Text] [Related]
20. T lymphocyte cloning from rejected human kidney allograft. Recognition repertoire of alloreactive T cell clones. Bonneville M; Moreau JF; Blokland E; Pool J; Moisan JP; Goulmy E; Soulillou JP J Immunol; 1988 Dec; 141(12):4187-95. PubMed ID: 3058801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]